Morgan Stanley Silo Pharma, Inc. Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SILO
# of Institutions
10Shares Held
95.6KCall Options Held
0Put Options Held
0-
Virtu Financial LLC New York, NY41.8KShares$48,5430.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$18,9470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA16.2KShares$18,7670.0% of portfolio
-
State Street Corp Boston, MA12.5KShares$14,4990.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY6.66KShares$7,7290.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $3.64M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...